Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial

Abstract

loading...

About

This paper, published in 1950, received 364 indexed citations. Written by Sepideh Rahmani, Sedigheh Asgary, Gholamreza Askari, Mahtab Keshvari, Mahdi Hatamipour, Awat Feizi and Amirhossein Sahebkar covering the research area of Epidemiology, Hepatology and Molecular Medicine. It is primarily cited by scholars working on Molecular Medicine (213 citations), Epidemiology (146 citations) and Endocrinology, Diabetes and Metabolism (95 citations). Published in Phytotherapy Research.

In The Last Decade

doi.org/10.1002/ptr.5659 →

Countries where authors are citing Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial

Since Specialization
Citations

This map shows the geographic impact of Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial more than expected).

Fields of papers citing Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/ptr.5659.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Statistically rigorous java performance evaluation Breakdown of academic impact, for the paper Design of Collective Motions from Synthetic Molecular Switches, Rotors, and Motors Breakdown of academic impact, for the paper Complete nucleotide sequences of all three poliovirus serotype genomes Breakdown of academic impact, for the paper Going beyond nutrition: Regulation of potassium homoeostasis as a common denominator of plant adaptive responses to environment Breakdown of academic impact, for the paper Extremely stretchable and self-healing conductor based on thermoplastic elastomer for all-three-dimensional printed triboelectric nanogenerator Breakdown of academic impact, for the paper The teleparallel equivalent of general relativity Breakdown of academic impact, for the paper High-Pressure Methane Adsorption and Characterization of Pores in Posidonia Shales and Isolated Kerogens Breakdown of academic impact, for the paper The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome
Rankless by CCL
2026